Successful Treatment of Toxic Epidermal Necrolysis with Intravenous Immunoglobulin
The Internet Journal of Asthma, Allergy and Immunology · 2009
DOI: 10.5580/171f ↗Kurz gefasst
Fachartikel in der Zeitschrift The Internet Journal of Asthma, Allergy and Immunology, 2009. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Toxic epidermal necrolysis (TEN) is a rare but potentially fatal delayed hypersensitivity reaction to numerous medications. Anticonvulsants are one of the most common ethiologic factors. The approved and controversial management strategies are still under consideration, including the administration of intravenous immunoglobulin (IVIG). We describe one patient who developed anticonvulsant-related TEN while using valproic acid and lamotrigine for epilepsy. The patient experienced systemic hypersensitivity rection with high fever, pain in the eyes and diffuse pruritic maculopapular eruption, which became vesicular and bullous, involved oral mucosa and conjunctiva. Diagnosis of TEN was considered, and previously used drugs were discontinued. In addition to standard treatment, IVIG was administered of 0.4 g/kg (30 g) a day for a 5-day-course. The treatment led to prevention of new blister formation and improvement of skin lesions. This case-report suggests that IVIG might be beneficial in the treatment of patients with TEN.
Zitieren
APA
(2009). Successful Treatment of Toxic Epidermal Necrolysis with Intravenous Immunoglobulin. The Internet Journal of Asthma, Allergy and Immunology. https://doi.org/10.5580/171f
Vancouver
Successful Treatment of Toxic Epidermal Necrolysis with Intravenous Immunoglobulin. The Internet Journal of Asthma, Allergy and Immunology. 2009. doi:10.5580/171f
BibTeX
@article{euvimed2009,
title = {Successful Treatment of Toxic Epidermal Necrolysis with Intravenous Immunoglobulin},
journal = {The Internet Journal of Asthma, Allergy and Immunology},
year = {2009},
doi = {10.5580/171f}
}
EUVIMED